Analog Devices (ADI) CEO sells 10K shares after option exercise
Rhea-AI Filing Summary
Analog Devices Chair and CEO Vincent Roche exercised stock options and sold shares in a routine, pre-planned transaction. On April 1, 2026, he exercised 10,000 Non-Qualified Stock Options at $94.41 per share, acquiring the same number of common shares.
That same day, he sold 10,000 common shares at an average price of $318.14 per share in an open-market transaction made under a Rule 10b5-1 trading plan adopted on May 23, 2025. After these transactions, Roche holds 167,825.875 common shares directly and 23,515 shares indirectly through the Vincent Roche 2024 Grantor Retained Annuity Trust. The reported option is fully vested and no remaining derivative position from this option is shown.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 10,000 shares ($2.24M approx. pre-tax spread)
Exercise and Sale
4 txns
Insider
ROCHE VINCENT
Role
Chair & CEO
Sold
10,000 shs ($3.18M)
Approx. gross sale proceeds
$3.18M
Approx. exercise cost
$944K
Approx. pre-tax spread
$2.24M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) | 10,000 | $94.41 | $944K |
| Exercise | Comm Stock - $.16-2/3 value | 10,000 | $94.41 | $944K |
| Sale | Comm Stock - $.16-2/3 value | 10,000 | $318.14 | $3.18M |
| holding | Comm Stock-$.16-2/3 value | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 24,637 shares (Direct);
Comm Stock - $.16-2/3 value — 167,825.875 shares (Direct);
Comm Stock-$.16-2/3 value — 23,515 shares (Indirect, Vincent Roche 2024 Grantor Retained Annuity Trust)
Footnotes (3)
- F1. These shares were sold pursuant to a 10b5-1 plan adopted by the reporting person on May 23, 2025.
- F2. Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024.
- F3. This option is fully vested.
Key Figures
Options exercised: 10,000 shares
Option exercise price: $94.41/share
Shares sold: 10,000 shares
+4 more
7 metrics
Options exercised
10,000 shares
Non-Qualified Stock Options exercised on April 1, 2026
Option exercise price
$94.41/share
Exercise price for 10,000 Non-Qualified Stock Options
Shares sold
10,000 shares
Common stock sold in open market on April 1, 2026
Sale price
$318.14/share
Average price for 10,000 common shares sold
Direct holdings after
167,825.875 shares
Common stock directly owned following the transactions
Indirect trust holdings
23,515 shares
Shares held by Vincent Roche 2024 Grantor Retained Annuity Trust
Option expiration
March 11, 2030
Expiration date of exercised stock option grant
Key Terms
Non-Qualified Stock Option, Rule 10b5-1 trading plan, Grantor Retained Annuity Trust, open-market sale, +1 more
5 terms
Non-Qualified Stock Option financial
"10,000 Non-Qualified Stock Options at $94.41 per share"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Rule 10b5-1 trading plan regulatory
"sold pursuant to a 10b5-1 plan adopted by the reporting person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Grantor Retained Annuity Trust financial
"Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
open-market sale financial
"Sale in open market or private transaction"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
fully vested financial
"This option is fully vested"
FAQ
What did Analog Devices (ADI) CEO Vincent Roche report in this Form 4?
Vincent Roche reported exercising 10,000 stock options and selling 10,000 Analog Devices common shares. The filings show these were routine transactions, converting options into shares and then selling those shares on the open market.
How many Analog Devices (ADI) options did Vincent Roche exercise and at what price?
He exercised 10,000 Non-Qualified Stock Options at an exercise price of $94.41 per share. This converted derivative rights into 10,000 shares of Analog Devices common stock on April 1, 2026, before the same number of shares was later sold.
What does it mean that Vincent Roche’s Analog Devices option is fully vested?
Fully vested means Roche had earned the right to exercise all 10,000 optioned shares without further service or performance conditions. The filing notes this option is fully vested, and the reported exercise used the entire 10,000-share grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
